Why the study?
Is screening for cardiovascular risk factors cost-effective in middle-aged men and women?
Population
Middle aged men and women
Authors
Loading...
Screening may not be cost-effective unless benefits persist ≥5 years; leaves open the durability of risk reduction effects.
Is screening for cardiovascular risk factors cost-effective in middle-aged men and women?
Cardiovascular screening programs require the risk reduction effect to persist for at least 5 to 10 years to be considered cost-effective.
Wonderling et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: